Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

HOMOCYSTEINE - ANVISA Registration 80020690414

Access comprehensive regulatory information for HOMOCYSTEINE in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80020690414 and manufactured by BIO-RAD LABORATORIES, INC. The registration is held by BIO-RAD LABORATORIOS BRASIL LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 companies making the same product including ROCHE DIAGNOSTICS GMBH, ABBOTT GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
80020690414
Registration Details
ANVISA Registration Number: 80020690414
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Família InteliQ Homocysteine Control
Risk Class II

Registration Details

80020690414

25351851048202162

03188198000177

Company Information

United States of America
PT: ESTADOS UNIDOS DA AMÉRICA

Dates and Status

Aug 12, 2021

VIGENTE

09/18/2025 19:00:01